A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis

Figure 2

Mean value (a) and absolute change value (b) of WOMAC pain changes from baseline to 4, 8, and 12 weeks in the control group (■: (a), ●: (b); glucosamine 1500 mg per day), Group A (: (a), ○: (b); Polycan 50 mg and glucosamine 750 mg per day), and Group B (: (a), ▼: (b); Polycan 50 mg and glucosamine 1500 mg per day), respectively, in this clinical study (p<0.05 compared to control).

(a)

(b)